Celularity (CELU) - 2025 Q1 - Quarterly Results

Exhibit 99.1 Celularity Announces Full Year 2024 Operating and Financial Results ● Net revenues for the year ending December 31, 2024, totaled $54.2 million, an increase of $31.4 million, or 138.1%, compared to the previous year. FLORHAM PARK, N.J., [DATE], May 9, 2025 (GLOBE NEWSWIRE) — Celularity Inc. (Nasdaq: CELU) ("Celularity" or the "Company"), a regenerative and cellular medicine company, today announced operating and financial results for the year ended December 31, 2024. "We built momentum through ...